Center for Financial Planning’s Avanos Medical AVNS Stock Holding History

Center for Financial Planning’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3	Closed	–	–	554
2022 Q3	$0	Buy	+3	New	+$78	﹤0.01%	637

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Center for Financial Planning's AVNS Position: Q4 2022 in Review

Center for Financial Planning sold out of Avanos Medical (AVNS) in Q4 2022, closing a stake of 3 shares.

Center for Financial Planning first reported a position in AVNS in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

Center for Financial Planning reported no remaining Avanos Medical position as of Q4 2022 after selling out during the quarter.
Center for Financial Planning sold 3 Avanos Medical shares in Q4 2022.
Center for Financial Planning first reported a position in Avanos Medical in Q3 2022 and held it in 1 quarter.
Center for Financial Planning's Avanos Medical position peaked at $0 in Q3 2022.
288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on Center for Financial Planning's 13F filing for Q4 2022, filed 27 Jan 2023.